PR 2022
BIOCORP announces its certification to the new European Medical Device Regulation
221220 PR_BIOCORP
BIOCORP obtains 510(k) FDA clearance for Mallya®
221207 PR_BIOCORP
BIOCORP and NOVO NORDISK strengthen their partnership with a new agreement on Mallya® smart sensor
221026 PR_BIOCORP
BD, BIOCORP sign agreement to bring connectivity, traceability to self-administered injectable drugs
221018 PR BIOCORP BD
BIOCORP and MERCK KGAA, DARMSTADT, GERMANY, sign a new partnership for smart drug delivery
221010 PR_BIOCORP
BIOCORP reports half-year results as of June 30, 2022
220929 PR_BIOCORP
BIOCORP announces the CE marking of SoloSmart®, an accessory medical device for SANOFI Solostar® pens at the occasion of EASD
220919 PR_BIOCORP
BIOCORP: its range of connected devices featured at several international conferences and exhibitions
220901 PR_BIOCORP
BIOCORP: AARDEX® Group and BIOCORP recruited by Trials@Home – Decentralized Clinical Trial Centre of Excellence
220721 PR_BIOCORP
BIOCORP: Full-Year 2021 financial results
220405 PR_BIOCORP
